Showing results (1881-1890 of 5,493) with videos related to
Sort By:
Pageof 550
Pharmacotherapy|May 14, 2003
A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonatesRobert DiCenzo, Alan Forrest, Judianne C Slish, et al.Pharmacotherapy|May 14, 2003
Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infections. Insights from the Society of Infectious Diseases PharmacistsElizabeth A Coyle, Pharmacotherapy|May 14, 2003
Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicityWilliam Darko, Joseph J Medicis, Adrienne Smith, et al.Pharmacotherapy|May 14, 2003
Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvementEllen L Toth, Sumit R Majumdar, Lisa M Guirguis, et al.Pharmacotherapy|June 25, 2003
Risperidone-associated diabetes mellitus: a pharmacovigilance studyElizabeth A Koller, James T Cross, P Murali Doraiswamy, et al.Pharmacotherapy|June 25, 2003
Better living through chemistry: does it still apply to patients after myocardial infarction?Thomas F Oppelt, Rodel V BobadillaPharmacotherapy|March 12, 2003
Disposition of cefepime in the central nervous system of patients with external ventricular drainsDenise H Rhoney, Vincent H Tam, Dennis Parker, et al.Pharmacotherapy|March 12, 2003
Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancerMcDonald K Horne, William D Figg, Phil Arlen, et al.Pharmacotherapy|February 18, 2003
Reteplase for dysfunctional hemodialysis catheter clearanceDaniel E Hilleman, Robert W Dunlay, Kathleen A PackardPharmacotherapy|February 18, 2003
Heparin resistance as detected with an antifactor Xa assay is not more common in venous thromboembolism than in other thromboembolic conditionsTerry K Rosborough, Michele E ShepherdPageof 550